Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer
1670.9000 -1.60 (-0.10%)
NSE Jul 09, 2025 11:16 AM
Volume: 500.8K
 

logo
Sun Pharmaceutical Industries Ltd.
29 Oct 2024
1670.90
-0.10%
buy
by BOB Capital Markets Ltd.
Target: 2019 | Upside : 20.8%
BOB Capital Markets Ltd.
SUNP reported 11% domestic sales growth led by 5% volume growth from ~14,000 MRs; leads in Rx count across 13 doctor categories
 
Promoters pledged 0.19% of shares in last quarter. Total pledge stands at 0.88% of promoter holdings
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market trades flat, Union Bank's Q1FY26 total business reaches Rs 22.1 lakh crore
Trendlyne Marketwatch | 09 Jul 2025, 11:02AM
Five stocks to buy from analysts this week - July 08, 2025
The Baseline | 08 Jul 2025, 05:56PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022